TARIS Bio

Our drug candidates are delivered continuously to the patient’s #bladder using our proprietary TARIS System. After demonstrating safety & tolerability, the system has been administered to over 400 individuals across multiple diseases. Learn more here: bit.ly/2ZMrmxK

Many people think loss of #bladder control is a female-only problem. Actually, that’s not true. Can you guess how many men across the globe suffer from incontinence?

Are you a patient living with muscle-invasive bladder cancer or #OveractiveBladder? Learn more about our ongoing clinical trials: bit.ly/2J3PNkl #BladderCancer #BladdersMatter #TARISBio

Loss of #bladder control is nothing to be ashamed about. Your healthcare provider can find the right course of action for you. Our resources tab can help point you in the right direction: bit.ly/2DHYbSQ

With our three-pronged approach to developing potential treatment options for diseases of the #bladder, patients can spend their time enjoying life, not managing disease. Learn more about our scientific approach here: bit.ly/2ZMrmxK #TARISBio #BladdersMatter

#FunFact: Did you know that when the #bladder is not full, it’s about the size and shape of a pear? Learn more interesting facts about the bladder in the latest @UrologyCareFdn infographic on incontinence. #BladdersMatter bit.ly/1OPeDhJ

This giving season, the #TARISBio team came together to assemble 100 bags of food for children in need. And we had a great time doing it! Thank you for the opportunity, @OpenTableMA! #Thanksgiving #GiveBack

OAB isn't a disease—it's the name given to a group of troubling urinary symptoms. Get the facts: bit.ly/2ymkQBw #BladdersMatter @UrologyCareFdn

It’s the last week of #NationalBladderHealthMonth. This week, @UrologyCareFdn is shining the spotlight on #overactivebladder, another area we know well. Our clinical program in overactive bladder has the potential to establish new standards of care.

Interesting research published in @urotoday on the impact of patient characteristics in prediction of recurrence in non-muscle invasive bladder cancer patients. bit.ly/32Sscdy

Welcome to week 4 of #NationalBladderHealthMonth. This week @UrologyCareFdn is focusing on one topic we know well, #bladdercancer. The #TARISBio team is working to advance treatments for muscle-invasive bladder cancer. View more about our pipeline here: bit.ly/33ccGJz

Today is officially #BladdersMatter Day of Thanks in honor of Bladder Health Month! @UrologyCareFdn Here at #TARISBio we know bladders matter, and we’re doing everything we can to advance treatments for those with #bladdercancer and #overactivebladder.

The bladder has a vast impact on Americans and for patients, the impact spans every part of their life. Our lead clinical programs aim to respond to an unmet need identified by urologists and patients for targeted solutions to address the debilitating effect the conditions pose.

We were proud to support a recent nationwide, population-based analysis of patients with organ-confined, muscle-invasive bladder cancer in Sweden. View the abstract, results and conclusions here: bit.ly/2WMfPxs

We couldn’t agree more. Working toward improving patient quality of life is what keeps our team going. @GBUrology

November marks #NationalBladderHealthMonth! @UrologyCareFdn shared tips on how you can keep your bladder healthy. #BladdersMatter: bit.ly/2qheT87

Although there are many bladder cancer risk factors we can’t avoid, @usnews shared three significant risk factors you can influence: bit.ly/2meFJMe #BladderCancer #BladdersMatter

The #TARISBio team is celebrating another great week with a bake-off and #FlannelFriday! We work hard to foster an environment where we prioritize our company mission alongside quality time to connect and share laughs as a team.

The #bladder is more intelligent than we think. But, with this complex intelligence comes challenges in treating disease. That’s why here at #TARISBio we’re looking to break free from traditional therapeutic approaches and create a local, continuous treatment option.